NCT07151807View on ClinicalTrials.gov

Serum IGF-1 and IGF-1Ec in Malignancy Assessment

Active, not recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

CancerSolid Tumor MalignanciesIGF1RSolid Cancers

Trial Locations (1)

17020

Çanakkale Onsekiz Mart University, Çanakkale

All Listed Sponsors

lead

Çanakkale Onsekiz Mart University

OTHER